300138 晨光生物
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额197,432(588,469)734,80763,900529,413
投资活动产生之现金流量净额472,134(448,268)(696,404)(264,757)(442,143)
筹资活动产生之现金流量净额466,1601,296,81639,045540,964242,661
汇率变动对现金及现金等价物的影响(2,405)(6,050)(4,938)(4,361)(3,907)
现金及现金等价物净增加/(减少)1,133,321254,02972,511335,745326,024
期初现金及现金等价物余额1,085,265831,236758,725422,98096,956
期末现金及现金等价物余额2,218,5861,085,265831,236758,725422,980